JP2000516807A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000516807A5 JP2000516807A5 JP1998508087A JP50808798A JP2000516807A5 JP 2000516807 A5 JP2000516807 A5 JP 2000516807A5 JP 1998508087 A JP1998508087 A JP 1998508087A JP 50808798 A JP50808798 A JP 50808798A JP 2000516807 A5 JP2000516807 A5 JP 2000516807A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2299996P | 1996-08-02 | 1996-08-02 | |
| US60/022,999 | 1996-08-02 | ||
| US08/740,223 US6265564B1 (en) | 1996-08-02 | 1996-10-25 | Expressed ligand-vascular intercellular signalling molecule |
| US08/740,223 | 1996-10-25 | ||
| PCT/US1997/013557 WO1998005779A1 (en) | 1996-08-02 | 1997-08-01 | Modified tie-2-receptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000516807A JP2000516807A (ja) | 2000-12-19 |
| JP2000516807A5 true JP2000516807A5 (cg-RX-API-DMAC7.html) | 2005-04-07 |
| JP3977434B2 JP3977434B2 (ja) | 2007-09-19 |
Family
ID=26696604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50808798A Expired - Lifetime JP3977434B2 (ja) | 1996-08-02 | 1997-08-01 | 改変ｔｉｅ―２レセプターリガンド |
Country Status (20)
| Country | Link |
|---|---|
| US (5) | US6265564B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP0915974B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3977434B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100481560B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1171997C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE262037T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU724032C (cg-RX-API-DMAC7.html) |
| CA (1) | CA2262409C (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ295371B6 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69728149T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0915974T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2216163T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HU227995B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL128311A (cg-RX-API-DMAC7.html) |
| NO (1) | NO990470L (cg-RX-API-DMAC7.html) |
| NZ (2) | NZ333994A (cg-RX-API-DMAC7.html) |
| PL (1) | PL189639B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT915974E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2233880C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998005779A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6265564B1 (en) * | 1996-08-02 | 2001-07-24 | Regeneron Pharmaceuticals, Inc. | Expressed ligand-vascular intercellular signalling molecule |
| US6030831A (en) | 1997-09-19 | 2000-02-29 | Genetech, Inc. | Tie ligand homologues |
| US6348350B1 (en) | 1997-09-19 | 2002-02-19 | Genentech, Inc. | Ligand homologues |
| AU4643699A (en) * | 1998-06-24 | 2000-01-10 | Compugen Ltd. | Angiopoietin-like growth factor sequences |
| US7008781B1 (en) * | 1998-12-23 | 2006-03-07 | Regeneron Pharmaceuticals, Inc. | Method of enhancing the biological activity of ligands |
| US6455035B1 (en) | 1999-03-26 | 2002-09-24 | Regeneron Pharmaceuticals, Inc. | Angiopoietins and methods of use thereof |
| CA2397833A1 (en) * | 2000-01-20 | 2001-07-26 | Hadasit Medical Research Services & Development Company Ltd. | Novel haptotactic peptides |
| CA2417507A1 (en) | 2000-08-21 | 2002-02-28 | Pacific Corporation | Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| US6753321B2 (en) | 2000-09-15 | 2004-06-22 | Genvec, Inc. | Method of modulating neovascularization |
| US7658924B2 (en) | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
| US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
| US7205275B2 (en) | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
| US7521053B2 (en) | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
| AU2002335085A1 (en) | 2001-10-25 | 2003-05-06 | Regeneron Pharmaceuticals, Inc. | Angiopoietins and methods of use thereof |
| AU2002359464A1 (en) * | 2001-11-30 | 2003-06-17 | Genvec, Inc. | Angiopioetin related factors |
| US7081443B2 (en) | 2002-05-21 | 2006-07-25 | Korea Advanced Institutes Of Science And Technology (Kaist) | Chimeric comp-ang1 molecule |
| WO2004076650A2 (en) * | 2003-02-27 | 2004-09-10 | The Trustees Of The University Of Pennsylvania | Angiopoietin and fragments, mutants, and analogs thereof and uses of the same |
| WO2005013890A2 (en) * | 2003-05-29 | 2005-02-17 | The Trustees Of The University Of Pennsylvania | Function and regulation of angiopoietin-3/angiopoietin-4 |
| US7871610B2 (en) * | 2003-08-12 | 2011-01-18 | Dyax Corp. | Antibodies to Tie1 ectodomain |
| US7485297B2 (en) * | 2003-08-12 | 2009-02-03 | Dyax Corp. | Method of inhibition of vascular development using an antibody |
| JP2007528720A (ja) * | 2003-08-12 | 2007-10-18 | ダイアックス コーポレイション | Ｔｉｅ１結合リガンド |
| CN1323723C (zh) * | 2003-12-26 | 2007-07-04 | 上海新世界基因技术开发有限公司 | Tie2受体介导的靶向性肿瘤基因治疗的基因转移系统 |
| US8298532B2 (en) | 2004-01-16 | 2012-10-30 | Regeneron Pharmaceuticals, Inc. | Fusion polypeptides capable of activating receptors |
| WO2006068953A2 (en) | 2004-12-21 | 2006-06-29 | Astrazeneca Ab | Antibodies directed to angiopoietin-2 and uses thereof |
| US20080213253A1 (en) * | 2007-01-12 | 2008-09-04 | Dyax Corp. | Combination therapy for the treatment of cancer |
| JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
| CA2729012A1 (en) | 2008-06-27 | 2009-12-30 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
| US9434925B2 (en) * | 2009-04-13 | 2016-09-06 | Apceth Gmbh & Co. Kg | Genetically modified mesenchymal stem cell that express an exogenous cytotoxic protein |
| DK2714738T3 (en) | 2011-05-24 | 2019-01-28 | Zyngenia Inc | MULTIVALENT AND MONOVALENT MULTISPECIFIC COMPLEXES AND THEIR APPLICATIONS |
| KR101967345B1 (ko) * | 2012-10-18 | 2019-04-09 | 삼성전자주식회사 | 안지오포이에틴-2와 인테그린 간의 결합을 저해하는 펩타이드 및 그 용도 |
| EA201890895A1 (ru) | 2013-03-15 | 2019-02-28 | Зинджения, Инк. | Мультивалентные и моновалентные мультиспецифические комплексы и их применение |
| RU2538701C1 (ru) * | 2013-07-11 | 2015-01-10 | Федеральное государственное бюджетное учреждение науки "Тюменский научный центр Сибирского отделения РАН" (ТюмНЦ СО РАН) | Способ извлечения куриного эмбриона из яйца для дальнейшего получения клеточных трансплантатов из фетальных тканей |
| CA2961340C (en) | 2014-09-26 | 2023-10-17 | Somalogic, Inc. | Cardiovascular risk event prediction and uses thereof |
| US10588940B2 (en) | 2015-11-06 | 2020-03-17 | Regeneron Pharmaceuticals, Inc. | Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5070192A (en) * | 1988-03-23 | 1991-12-03 | The Johns Hopkins University | Cloned human topoisomerase i: cdna expression, and use for autoantibody detection |
| US5814464A (en) * | 1994-10-07 | 1998-09-29 | Regeneron Pharma | Nucleic acids encoding TIE-2 ligand-2 |
| JP4122056B2 (ja) * | 1995-04-06 | 2008-07-23 | リジエネロン ファーマシューティカルズ，インコーポレイテッド | Ｔｉｅ−２リガンド、その作製方法および使用方法 |
| US6265564B1 (en) | 1996-08-02 | 2001-07-24 | Regeneron Pharmaceuticals, Inc. | Expressed ligand-vascular intercellular signalling molecule |
-
1996
- 1996-10-25 US US08/740,223 patent/US6265564B1/en not_active Expired - Lifetime
-
1997
- 1997-08-01 AU AU39687/97A patent/AU724032C/en not_active Expired
- 1997-08-01 AT AT97937086T patent/ATE262037T1/de active
- 1997-08-01 CA CA002262409A patent/CA2262409C/en not_active Expired - Lifetime
- 1997-08-01 EP EP97937086A patent/EP0915974B1/en not_active Expired - Lifetime
- 1997-08-01 HU HU0400256A patent/HU227995B1/hu unknown
- 1997-08-01 NZ NZ333994A patent/NZ333994A/en not_active IP Right Cessation
- 1997-08-01 CN CNB971985316A patent/CN1171997C/zh not_active Expired - Lifetime
- 1997-08-01 DE DE69728149T patent/DE69728149T2/de not_active Expired - Lifetime
- 1997-08-01 KR KR10-1999-7000894A patent/KR100481560B1/ko not_active Expired - Lifetime
- 1997-08-01 CZ CZ1999310A patent/CZ295371B6/cs not_active IP Right Cessation
- 1997-08-01 RU RU99105129/13A patent/RU2233880C2/ru active
- 1997-08-01 JP JP50808798A patent/JP3977434B2/ja not_active Expired - Lifetime
- 1997-08-01 PT PT97937086T patent/PT915974E/pt unknown
- 1997-08-01 NZ NZ505684A patent/NZ505684A/en not_active IP Right Cessation
- 1997-08-01 ES ES97937086T patent/ES2216163T3/es not_active Expired - Lifetime
- 1997-08-01 IL IL128311A patent/IL128311A/en not_active IP Right Cessation
- 1997-08-01 DK DK97937086T patent/DK0915974T3/da active
- 1997-08-01 WO PCT/US1997/013557 patent/WO1998005779A1/en not_active Ceased
- 1997-08-01 PL PL97331405A patent/PL189639B1/pl unknown
-
1999
- 1999-02-01 NO NO990470A patent/NO990470L/no not_active Application Discontinuation
-
2000
- 2000-11-09 US US09/709,188 patent/US6441137B1/en not_active Expired - Lifetime
-
2002
- 2002-08-21 US US10/225,060 patent/US6825008B2/en not_active Expired - Lifetime
-
2004
- 2004-08-27 US US10/928,911 patent/US20050106099A1/en not_active Abandoned
-
2005
- 2005-03-04 US US11/073,120 patent/US7045302B2/en not_active Expired - Fee Related